Koers Pharmacyte Biotech Inc Other OTC
Aandelen
US67090R1005
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 50,93 mln. 46,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -4 mln. -3,67 mln. | Nettowinst (verlies) 2023 | -4 mln. -3,67 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 85,4 mln. 78,43 mln. | Nettoliquiditeiten 2023 | 68,04 mln. 62,48 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-8,53
x | K/w-verhouding 2023 |
-13,2
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 35,95% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15-08-22 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01-01-15 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10-08-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14-11-22 |
Joshua Silverman
CEO | Chief Executive Officer | 53 | 15-08-22 |
Wayne Walker
BRD | Director/Board Member | 65 | 28-12-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,60% | 364 mld. | |
+20,83% | 326 mld. | |
+5,69% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+10,77% | 167 mld. | |
+0,10% | 161 mld. |
- Beurs
- Aandelen
- Koers PMCB
- Koers